News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Biotrial Is Pleased To Announce That It Will Be Exhibiting At The 20th AGAH (Association For Applied Human Pharmacology) Annual Meeting


2/9/2010 1:27:47 PM

Biotrial is pleased to announce that it will be exhibiting at the 20th AGAH (Association for Applied Human Pharmacology) Annual Meeting in Hamburg, Germany and at the 9th Annual Phase I Clinical Trials in London, UK. During the 20th AGAH Annual Meeting (http://www.agah.info) from February 21st–23rd, 2010, Biotrial will be exhibiting at Booth #10. This event will review past and present approaches to drug development, and will take a close look at special populations, difficult pharmacokinetic conditions and how to adapt to changing regulatory environments.

From February 23rd–24th, 2010 at the 11th Annual Phase I Clinical Trials (http://www.iir-events.com) Biotrial will be located at Booth #8. Alain Patat, VP Medical Scientific & Quality Affairs at Biotrial, said: “I am looking forward to attending this event, which focuses this year on assessing the significant advances in scientific and technological approaches for obtaining clinical data at earlier stages of drug development. This is a subject of interest for Biotrial who has been involved and committed for many years now to help the life science industry achieve great milestones in early compound development."

Both of these events provide great platforms to share information and experiences and are an opportunity for Biotrial to meet with our present and future customers. We invite you to visit us at the booth locations indicated, or to contact one of our representatives to schedule an individual meeting: Matthew Koneth (matthew.konneh@biotrial.com) for the Phase I event in London, and Anna Lainé at (anna.laine@biotrial.com) for the AGAH meeting in Germany.

About Biotrial

Founded in 1989 by Jean-Marc Gandon, PharmD, (President & CEO), Biotrial (www.biotrial.com) is an independent and privately owned CRO. With 150 beds and a staff of 250 in several subsidiaries in France and the UK, Biotrial runs over 80 studies per year, either in their own clinics in Paris and Rennes, or in cooperation with hospital specialists and general practitioners.

With a large range of services from Phase I studies, Clinical Trial Management Phase II-IV, Oncology, Data Management, Biostatistics, Core Lab (ECG, MRI), Medical Writing, Non-Clinical Pharmacology, QA & advice in Regulatory Affairs, Biotrial can manage every step of your development process. For further information please contact Anne Peron at [+33] (0)2 99 599 191 or visit www.biotrial.com. Press Release / Story Biotrial, a key CRO player for early drug development in healthy volunteers and patients, to exhibit at two major life science conferences in February 2010.

Read at BioSpace.com

comments powered by Disqus
Biotrial
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES